Literature DB >> 32378163

Big Data and Atrial Fibrillation: Current Understanding and New Opportunities.

Qian-Chen Wang1,2, Zhen-Yu Wang3.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia with diverse etiology that remarkably relates to high morbidity and mortality. With the advancements in intensive clinical and basic research, the understanding of electrophysiological and pathophysiological mechanism, as well as treatment of AF have made huge progress. However, many unresolved issues remain, including the core mechanisms and key intervention targets. Big data approach has produced new insights into the improvement of the situation. A large amount of data have been accumulated in the field of AF research, thus using the big data to achieve prevention and precise treatment of AF may be the direction of future development. In this review, we will discuss the current understanding of big data and explore the potential applications of big data in AF research, including predictive models of disease processes, disease heterogeneity, drug safety and development, precision medicine, and the potential source for big data acquisition. Grapical abstract.

Entities:  

Keywords:  Atrial fibrillation; Big data; Machine learning; Precision medicine

Mesh:

Year:  2020        PMID: 32378163     DOI: 10.1007/s12265-020-10008-5

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  52 in total

1.  The inevitable application of big data to health care.

Authors:  Travis B Murdoch; Allan S Detsky
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

Review 2.  Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation.

Authors:  Jeffrey I Weitz; Jeffrey S Healey; Allan C Skanes; Atul Verma
Journal:  Circulation       Date:  2014-04-22       Impact factor: 29.690

3.  Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.

Authors:  James D Lewis; Rita Schinnar; Warren B Bilker; Xingmei Wang; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-04       Impact factor: 2.890

4.  Atrial fibrillation and cognitive decline in the Framingham Heart Study.

Authors:  Arvind Nishtala; Ryan J Piers; Jayandra J Himali; Alexa S Beiser; Kendra L Davis-Plourde; Jane S Saczynski; David D McManus; Emelia J Benjamin; Rhoda Au
Journal:  Heart Rhythm       Date:  2017-09-22       Impact factor: 6.343

5.  Epidemiology of atrial fibrillation.

Authors:  David Conen
Journal:  Eur Heart J       Date:  2018-04-21       Impact factor: 29.983

Review 6.  Translational Challenges in Atrial Fibrillation.

Authors:  Jordi Heijman; Jean-Baptiste Guichard; Dobromir Dobrev; Stanley Nattel
Journal:  Circ Res       Date:  2018-03-02       Impact factor: 17.367

7.  Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation.

Authors:  Shirley V Wang; James R Rogers; Yinzhu Jin; David DeiCicchi; Sara Dejene; Jean M Connors; David W Bates; Robert J Glynn; Michael A Fischer
Journal:  BMJ Qual Saf       Date:  2019-06-26       Impact factor: 7.035

8.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

9.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

10.  Identification of atrial fibrillation associated genes and functional non-coding variants.

Authors:  Antoinette F van Ouwerkerk; Fernanda M Bosada; Karel van Duijvenboden; Matthew C Hill; Lindsey E Montefiori; Koen T Scholman; Jia Liu; Antoine A F de Vries; Bastiaan J Boukens; Patrick T Ellinor; Marie José T H Goumans; Igor R Efimov; Marcelo A Nobrega; Phil Barnett; James F Martin; Vincent M Christoffels
Journal:  Nat Commun       Date:  2019-10-18       Impact factor: 14.919

View more
  3 in total

1.  Research output of artificial intelligence in arrhythmia from 2004 to 2021: a bibliometric analysis.

Authors:  Junlin Huang; Yang Liu; Shuping Huang; Guibao Ke; Xin Chen; Bei Gong; Wei Wei; Yumei Xue; Hai Deng; Shulin Wu
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

2.  Effect of an artificial intelligence-assisted tool on non-valvular atrial fibrillation anticoagulation management in primary care: protocol for a cluster randomized controlled trial.

Authors:  Xueying Ru; Lan Zhu; Yunhui Ma; Tianhao Wang; Zhigang Pan
Journal:  Trials       Date:  2022-04-15       Impact factor: 2.728

Review 3.  Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care.

Authors:  Jordi Heijman; Henry Sutanto; Harry J G M Crijns; Stanley Nattel; Natalia A Trayanova
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.